Sharps Technology Inc (STSS) - Net Assets
Based on the latest financial reports, Sharps Technology Inc (STSS) has net assets worth $433.21 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($443.96 Million) and total liabilities ($10.75 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Sharps Technology Inc's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $433.21 Million |
| % of Total Assets | 97.58% |
| Annual Growth Rate | 5.62% |
| 5-Year Change | -6.32% |
| 10-Year Change | N/A |
| Growth Volatility | 130.31 |
Sharps Technology Inc - Net Assets Trend (2007–2024)
This chart illustrates how Sharps Technology Inc's net assets have evolved over time, based on quarterly financial data. Also explore Sharps Technology Inc assets under control for the complete picture of this company's asset base.
Annual Net Assets for Sharps Technology Inc (2007–2024)
The table below shows the annual net assets of Sharps Technology Inc from 2007 to 2024. For live valuation and market cap data, see STSS stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $2.00 Million | -74.84% |
| 2023-12-31 | $7.93 Million | -17.70% |
| 2022-12-31 | $9.64 Million | +207.41% |
| 2021-12-31 | $3.14 Million | +47.18% |
| 2020-12-31 | $2.13 Million | +279.88% |
| 2019-12-31 | $560.92K | -28.81% |
| 2007-12-31 | $787.96K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sharps Technology Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2181708100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $205.00 | 0.01% |
| Other Comprehensive Income | $23.29K | 1.17% |
| Other Components | $36.42 Million | 1824.42% |
| Total Equity | $2.00 Million | 100.00% |
Sharps Technology Inc Competitors by Market Cap
The table below lists competitors of Sharps Technology Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
As Commercial Industrial Company of Computers and Toys S.A.
AT:ASCO
|
$51.97 Million |
|
Duck Yang Ind
KO:024900
|
$51.97 Million |
|
Sunview Group Bhd
KLSE:0262
|
$52.03 Million |
|
Sangamo Therapeutics Inc
NASDAQ:SGMO
|
$52.04 Million |
|
Otto Holding AS
IS:OTTO
|
$51.90 Million |
|
SKY LIGHT HOLDINGS LTD
F:27L
|
$51.89 Million |
|
Chia Her Industrial Co Ltd
TW:1449
|
$51.86 Million |
|
Korea Electronic Certification Authority Inc
KQ:041460
|
$51.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sharps Technology Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,934,286 to 1,996,129, a change of -5,938,157 (-74.8%).
- Net loss of 9,296,202 reduced equity.
- Other comprehensive income decreased equity by 568,519.
- Other factors increased equity by 3,926,564.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-9.30 Million | -465.71% |
| Other Comprehensive Income | $-568.52K | -28.48% |
| Other Changes | $3.93 Million | +196.71% |
| Total Change | $- | -74.84% |
Book Value vs Market Value Analysis
This analysis compares Sharps Technology Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $27.85 | $1.84 | x |
| 2020-12-31 | $151.74 | $1.84 | x |
| 2021-12-31 | $113.97 | $1.84 | x |
| 2022-12-31 | $396.74 | $1.84 | x |
| 2023-12-31 | $202.93 | $1.84 | x |
| 2024-12-31 | $476.74 | $1.84 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sharps Technology Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -465.71%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 3.66x
- Recent ROE (-465.71%) is below the historical average (-240.04%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | -417.06% | -975.18% | 0.27x | 1.61x | $-3.37 Million |
| 2019 | -366.46% | 0.00% | 0.00x | 1.18x | $-2.11 Million |
| 2020 | -110.15% | 0.00% | 0.00x | 1.05x | $-2.56 Million |
| 2021 | -148.73% | 0.00% | 0.00x | 1.88x | $-4.98 Million |
| 2022 | -48.12% | 0.00% | 0.00x | 1.23x | $-5.60 Million |
| 2023 | -124.04% | 0.00% | 0.00x | 1.49x | $-10.64 Million |
| 2024 | -465.71% | 0.00% | 0.00x | 3.66x | $-9.50 Million |
Industry Comparison
This section compares Sharps Technology Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,863,507,886
- Average return on equity (ROE) among peers: -17.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sharps Technology Inc (STSS) | $433.21 Million | -417.06% | 0.02x | $51.94 Million |
| Akoya Biosciences Inc (AKYA) | $121.35 Million | -35.38% | 0.57x | $64.44 Million |
| Align Technology Inc (ALGN) | $1.35 Billion | 32.89% | 0.86x | $12.66 Billion |
| AngioDynamics Inc (ANGO) | $517.03 Million | -1.36% | 0.37x | $444.32 Million |
| AptarGroup Inc (ATR) | $2.71 Billion | 14.48% | 0.94x | $7.66 Billion |
| AtriCure Inc (ATRC) | $16.74 Million | -22.66% | 1.01x | $1.44 Billion |
| Avinger Inc (AVGR) | $-73.64 Million | 0.00% | 0.00x | $1.52 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $10.52 Million | -163.15% | 1.04x | $156.14 Million |
| Avantor Inc (AVTR) | $5.57 Billion | -9.53% | 1.12x | $5.43 Billion |
| Azenta Inc (AZTA) | $553.69 Million | -12.55% | 0.24x | $1.04 Billion |
| Baxter International Inc (BAX) | $7.87 Billion | 19.65% | 1.00x | $8.85 Billion |
About Sharps Technology Inc
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry. Its product lines focus on providing waste capabilities that incorporate syringe technologies. The company, through a digital asset treasury strategy, focuses on accumulating Solana (SOL), the native digital asset of the Solana blockchain. The company … Read more